Biotech

All Articles

Praxis epilepsy drug reduces seizures in stage 2 hearing

.Practice Precision Medicines has actually racked up another midphase win in epilepsy this year, wit...

Three directors surrender as Dyne articles mixed records for DMD prospect

.After running away a clinical hold numerous years back, Dyne Therapy has actually shown new stage 1...

Arrowhead fires off period 3 information in rare metabolic health condition ahead of market clash with Ionis

.Arrowhead Pharmaceuticals has actually presented its own give ahead of a possible showdown along wi...

Pfizer, Valneva show lyme disease chance effective for 2nd booster

.Pfizer and also Valneva might have concerning 2 even more years to hang around just before they cre...

Fierce Biotech Editor-in-Chief Ayla Ellison Talks Shop with Michelle Benz on the Future of Biotech.

.Allow's dive into a discussion with Ayla Ellison, Tough Biotech Editor-in-Chief and Michelle Benz a...

New data demonstrate how Bayer's asundexian stopped working to avoid strokes

.Bayer put on hold the phase 3 test for its element XIa prevention asundexian behind time in 2013 af...

Sanofi's tolebrutinib falls short 2 of 3 late-stage MS tests

.Sanofi is actually still set on taking its a number of sclerosis (MS) med tolebrutinib to the FDA, ...

Galapagos' stockpile as fund presents intent to shape its own evolution

.Galapagos is coming under additional pressure from entrepreneurs. Having actually created a 9.9% ri...

Cell- concentrated Sana gathers very first CSO-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our summary of substantial leadership hirings, firings an...

Allist settles Jacobio $21M, landing function in Mandarin KRAS ethnicity

.Shanghai Allist Pharmaceuticals has actually acquired itself a starring job in China's KRAS market,...